HOME >> BIOLOGY >> NEWS
Size matters: Preventing large mammal extinction

Saving large mammals such as elephants and rhino from extinction could be made more effective by focusing efforts on individual species as well as their habitats.

Scientists at the Zoological Society of London's Institute of Zoology (IoZ) and Imperial College London have identified fundamental new approaches to improve the success of large mammal conservation. Published today in the journal Science, the largest study of its kind analyses key factors linked to the extinction of mammals.

"Conservation biologists have always known that large bodied mammals are at greater risk of extinction," comments Professor Georgina Mace of the IoZ, "Now we understand the mechanisms, we are able to tailor conservation programmes dependant on size, to ensure they're more effective."

The study showed that extinction risk in smaller mammals, below approximately 3kg (about the weight of a small domestic cat), is determined primarily by the size and locations of their distributions, and the human impact to which they are exposed. Larger mammals have the additional pressure of biological disadvantages such as long gestation period and late weaning age to contend with, significantly increasing their susceptibility to extinction.

"In a world dominated by people, being big is substantially more of a disadvantage than we realised, which implies that the conservation of large mammals should assume a particular urgency," said Dr Marcel Cardillo of Imperial College London.

"From a conservation policy angle, the message would be: small may be conservable but it is a little trickier for the larger mammals," commented Dr Andy Purvis of Imperial College London.

The research findings suggest smaller species, of around less than 3kg, would benefit from conservation of their habitat area, whereas, larger bodied animals require a different approach, focusing upon the specific species, their biology and their habitat.

"This understanding enables
'"/>

Contact: Clare Kingston
clare.kingston@zsl.org
44-20-7449-6361
Imperial College London
21-Jul-2005


Page: 1 2

Related biology news :

1. Space matters: Estimating species diversity in the fossil record
2. Size matters: fish genitalia attractiveness vs. predatory escape value
3. Preventing and treating lung cancer -- ESMO explores collaboration to fight cancer on all fronts
4. Preventing cancer without killing cells
5. Preventing obesity in children -- research highlights physical activity levels
6. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
7. Preventing ventilation induced lung injury depends on giving the right number of sighs
8. Preventing bacterial biofilms could help fight TB
9. Preventing fetal exposure to popular acne drug
10. Preventing a pandemic: Study suggests strategies for containing a flu outbreak
11. Preventing muscle atrophy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Size matters Preventing large mammal extinction

(Date:12/3/2014)... , Dec. 2, 2014   Marvin ... deployed, innovative test solutions for military, aerospace, and ... version of its successful TS-900 PXI semiconductor ... and features of high-end systems to customers at ... value compared to traditional ATE. ...
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: